Harbour Investments’s Caribou Biosciences CRBU Stock Holding History

Harbour Investments’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Sell	1,135 -45	-4%	-$89	﹤0.01%	4023
2026 Q1	$2.24K	Buy	1,180 +180	+18%	+$309	﹤0.01%	3874
2025 Q4	$1.59K	Hold	1,000	–	–	﹤0.01%	3358
2025 Q3	$2.33K	Hold	1,000	–	–	﹤0.01%	3234
2025 Q2	$1.26K	Hold	1,000	–	–	﹤0.01%	3238
2025 Q1	$913	Hold	1,000	–	–	﹤0.01%	3258
2024 Q4	$1.59K	Hold	1,000	–	–	﹤0.01%	3062
2024 Q3	$1.96K	Hold	1,000	–	–	﹤0.01%	2928
2024 Q2	$1.64K	Hold	1,000	–	–	﹤0.01%	2864
2024 Q1	$5.14K	Hold	1,000	–	–	﹤0.01%	2472
2023 Q4	$5.73K	Hold	1,000	–	–	﹤0.01%	2361
2023 Q3	$4.78K	Buy	+1,000	New	+$6.2K	﹤0.01%	2294
2021 Q4	–	Sell	-16	Closed	–	–	2834
2021 Q3	$0	Buy	+16	New	+$391	﹤0.01%	3773

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbour Investments's CRBU Position: Q2 2026 in Review

Harbour Investments reduced its Caribou Biosciences (CRBU) stake by 3.8% in Q2 2026, selling an estimated $89 and leaving 1,135 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.

Harbour Investments first reported a position in CRBU in Q3 2021 and has held it in 13 quarters since. The position peaked at $5.73K in Q4 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Harbour Investments held 1,135 shares of Caribou Biosciences worth $2K as of Q2 2026.
Harbour Investments sold 45 Caribou Biosciences shares in Q2 2026, an estimated $89.
Caribou Biosciences made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4023 holding.
Harbour Investments first reported a position in Caribou Biosciences in Q3 2021 and has held it in 13 quarters since.
Harbour Investments's Caribou Biosciences position peaked at $5.73K in Q4 2023.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.